Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice
Pierfrancesco Visaggi(University of Pisa), Edoardo Savarino(University of Padua), Massimo Bellini(University of Pisa), Daria Maniero(University of Padua), Elisa Marabotto(Ospedale Policlinico San Martino), Greta Lorenzon(University of Padua), Matteo Ghisa(University of Padua), Brigida Barberio(Azienda Ospedaliera di Padova), Nicola de Bortoli(University of Pisa), Andrea Bottari(University of Pisa), Federica Baiano Svizzero(University of Pisa), I. Solinas(University of Pisa)
Cited by 27
Related Papers
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications
|Life|2024|226
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
|United European Gastroenterology Journal|2021|159
Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry
|Alimentary Pharmacology & Therapeutics|2020|130
The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The <scp>IFOS</scp> Consensus
|The Laryngoscope|2023|121
Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice
|Clinical Gastroenterology and Hepatology|2020|107